Log in  First Connection?

Abdominal ImagingArchives

Predictive value of high-risk esophageal varices in cirrhosis based on dual-energy CT combined with clinical and serologic features

 Published on 02/05/2025 |  Original article (Full-text)  | Chen Jiewen et al. | BMC Medical Imaging 2025; 25(1): 137

Esophageal gastric variceal bleeding (EGVB) is a common and severe complication occurring during the decompensated stage of portal hypertension in cirrhotic patients, marked by high mortality during acute episodes [1]. Approximately half of cirrhosis patients develop esophageal gastric varices, with...

Association of ultrasound signs of sarcopenia with serum ferritin levels and hepatic indices like NFS and FIB-4 in NAFLD patients

 Published on 25/04/2025 |  Original article (Full-text)  | Arasteh Bahar et al. | BMC Gastroenterology 2025; 25(1): 261

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide; its prevalence varies around the world depending on genetics, physical activity, socioeconomic conditions, and average calorie intake [1]. Its prevalence is estimated to be over 25% of the world population [2]....

Location of endoscopic retrograde cholangiopancreatography impacts fluoroscopy time: a multi-institutional retrospective study at tertiary academic centers

 Published on 18/04/2025 |  Original article (Full-text)  | Marino Daniel et al. | BMC Gastroenterology 2024; 25(1): 243

Ionizing radiation is increasingly used in the field of gastroenterology, most frequently during endoscopic retrograde cholangiopancreatography (ERCP). ERCP is a technically demanding procedure that combines endoscopy and fluoroscopyfor the diagnostic and therapeutic management of pancreatobiliary disease....

Gd-EOB-DTPA-enhanced MRI radiomics and deep learning models to predict microvascular invasion in hepatocellular carcinoma: a multicenter study

 Published on 11/04/2025 |  Original article (Full-text)  | Zhu Zhu et al. | BMC Medical Imaging 2025; 25(1): 105

Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and the fourth most lethal tumor worldwide [1]. The recurrence and metastasis rates are as high as 50–70% at 5 years after liver cancer resection and liver transplantation [2, 3]. Microvascular invasion (MVI) is defined as...